Spots Global Cancer Trial Database for cd8
Every month we try and update this database with for cd8 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC. | NCT03968419 | Non-small Cell ... | Canakinumab Pembrolizumab | 18 Years - | Novartis | |
Immunohistochemical Study of Chordomas to Improve Their Diagnosis and Prognosis Care | NCT04486820 | Chordoma | Analysis Immuno... | - | Centre Hospitalier Universitaire de Saint Etienne | |
Prognostic Biomarkers in Patients With Urothelial Carcinoma | NCT04872036 | Bladder Cancer | 18 Years - | Hellenic Cooperative Oncology Group | ||
A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours | NCT05397171 | Urinary Bladder... Colorectal Canc... Carcinoma, Non-... | AZD8853 Zirconium-89 cr... | 18 Years - 130 Years | AstraZeneca | |
Prognostic Biomarkers in Patients With Urothelial Carcinoma | NCT04872036 | Bladder Cancer | 18 Years - | Hellenic Cooperative Oncology Group |